New Scientist examines the boom in microbiome-focused therapeutics.
Yale researchers find that autism risk-linked genes are also associated with increased cognitive ability, according to the Independent.
In Nature this week: genome-mining tool to study modified peptides, variants linked to macular telangiectasia type 2, and more.
In a speech to Congress, President Donald Trump called the drug approval process at FDA "slow and burdensome."
CBC Marketplace commissions DNA testing of chicken sandwiches at Subway and other fast-food chains.
Variants in the IFITM3 gene affect inflammatory response to infection, UPI reports.
In Genome Research this week: algorithm to tease out strains from metagenomic sequences, drug resistance mechanisms in cancer cells, and more.
A floated budget plan could see non-military discretionary spending in the US — which includes science agency funding — fall, the New York Times reports.
Proove Biosciences had allegedly been paying doctors to perform its opioid risk and other genetic tests, Stat News reports.
Sequencing is enabling the roots of some rare diseases to be determined, the Financial Times reports.
In PNAS this week: flu susceptibility and Y chromosome variation in mice, deletion tied to epilepsy in dog breed, and more.
For those who are concerned about Trump administration actions related to science, a new column in Scientific American has suggestions for ways to fight back.
The Earth BioGenome Project plans to sequence all life on Earth, according to ScienceInsider.
An NC State researcher is exploring the use of CRISPR-Cas3 as an anti-microbial, Gizmodo reports.
In PLOS this week: a sequencing-based screen of Lyme disease-causing pathogen, the range of animals bitten by Anopheles darling mosquitoes in Peru, and more.
Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.
Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.
At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.
In Science this week: genetic target for urothelial bladder cancer treatment, and more.
Two neuroscientists write in Nature News that solving the "reproducibility crisis" in science may require changing the requirements for publication.
A Karmagenes researcher has lost his position after reportedly admitting to data fabrication, according to Retraction Watch.
A new study finds that adding missing good bacteria to the skin microbiome of atopic dermatitis patients decreases Staphylococcus aureus colonization.
In Nature this week: genomic analysis of prehistoric New Mexicans, a nanopore method for mapping DNA methylation, and more.
British researchers say they've been removed from EU grant applications, according to the Guardian.
Some 57 snow monkeys at a Japanese zoo were found to be rhesus macaque hybrids, which are banned in Japan.
Gladys Kong writes at Fortune that her STEM background has helped her as a CEO.
Social scientists report that the image of the 'lone scientist' might be deterring US students from STEM careers.
Postdocs supported by external funding are less likely to have access to paid parental leave, Nature News reports.
The US National Institutes of Health's new plan will bolster support for early- and mid-career investigators.